LCTX
Lineage Cell Therapeutics, Inc.
-0.03 (-2.80%)1.04USD345K成交股數263M市值–本益比(近四季)20.1股價營收比-61.3%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.1M-61% | 1.7M+15% | 6.6M+75% | 3.7M+161% | 2.8M+91% | 1.5M-28% | 3.8M+203% | 1.4M-56% | 1.4M | 2.1M | 1.2M | 3.2M |
| 營業成本 | – | – | – | – | – | 36K | 38K | 44K | 98K | – | 169K | 127K |
| 毛利 | – | – | – | – | – | 1.5M | 3.7M+247% | 1.4M-56% | 1.3M | – | 1.1M | 3.1M |
| 毛利率 | – | – | – | – | – | 97.6% | 99.0% | 96.9% | 93.2% | – | 86.4% | 96.1% |
| 研發費用 | 4.8M | 4.2M | 8.2M | 3.3M | 3.1M | 3.1M | 3.2M | 2.9M | 3.0M | – | 3.7M | 3.9M |
| 銷售管理費用 | 5.2M | 5.1M | 4.9M | 4.2M | 4.6M | 4.9M | 4.4M | 4.4M | 5.0M | – | 4.0M | 4.2M |
| 營業利益 | −8.9M-55% | −7.6M+17% | −6.5M+71% | −3.8M-35% | −19.8M+197% | −6.5M+2% | −3.8M-43% | −5.9M+17% | −6.7M | −6.4M | −6.7M | −5.0M |
| 營業利益率 | -834.7% | -440.2% | -99.1% | -102.9% | -715.4% | -433.1% | -101.6% | -416.7% | -461.3% | -304.7% | -538.1% | -155.8% |
| 稅後淨利 | 1.5M-105% | −4.8M+16% | 851K-128% | −29.8M+417% | −30.5M+366% | −4.1M-13% | −3.0M-57% | −5.8M+10% | −6.5M | −4.8M | −7.1M | −5.2M |
| 淨利率 | 138.6% | -279.0% | 12.9% | -809.0% | -1,101.8% | -275.6% | -80.3% | -409.1% | -453.0% | -228.7% | -570.6% | -162.1% |
| 稀釋 EPS | -0.03-77% | -0.03+50% | 0.00-100% | -0.13+333% | -0.13+225% | -0.02-33% | -0.02-50% | -0.030% | -0.04 | -0.03 | -0.04 | -0.03 |
| 稀釋股數 | 261M | 261M | 230M | 229M | 228M | 226M | 189M | 189M | 183M | – | 175M | 171M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 37.4M | 35.9M | 40.8M | 40.5M | 42.3M | 47.9M | 27.8M | 29.6M | 43.6M | 35.4M | 31.5M | 33.9M |
| 應收帳款 | 790K | 806K | 891K | 127K | 256K | 213K | 405K | 235K | 77K | 745K | 432K | 443K |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 106M | 110M | 113M | 89.6M | 90.8M | 112M | 96.6M | 103M | 108M | 101M | 106M | 112M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 46.4M | 56.8M | 69.2M | 68.8M | 43.7M | 34.1M | 31.8M | 35.9M | 37.5M | 39.0M | 39.5M | 40.4M |
| 股東權益 | 60.9M | 53.9M | 44.5M | 22.0M | 48.4M | 79.0M | 66.2M | 68.3M | 72.4M | 63.4M | 68.1M | 72.7M |
| 負債比 | 43.7% | 51.9% | 61.5% | 76.8% | 48.1% | 30.5% | 32.9% | 34.9% | 34.6% | 38.6% | 37.2% | 36.2% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −8.1M+65% | – | – | – | −4.9M | – | – | −5.8M | – | – | – |
| 資本支出 | – | 55K | – | – | – | 97K | – | – | 38K | – | – | – |
| 自由現金流 | – | −8.1M+63% | – | – | – | −5.0M | – | – | −5.8M | – | – | – |
| 折舊攤銷 | 187K | 188K | 186K | 178K | 171K | 164K | 141K | 142K | 153K | – | 143K | 138K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -471.5% | – | – | – | -331.8% | – | – | -403.1% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 2.5M
| 美國以外 | 2.5M | 100.0% | – |
|---|
產品／服務2025 年度 · 14.6M
| Collaboration Revenues | 13.6M | 93.5% | +67.0% |
|---|---|---|---|
| Royalties License And Other Revenues | 947K | 6.5% | -29.9% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 14.6M | +53.2% | −63.5M | -436.5% | -0.28 | −19.4M |
| FY2024 | 9.5M | +6.2% | −18.6M | -195.9% | -0.09 | −23.7M |
| FY2023 | 8.9M | -39.2% | −21.5M | -240.2% | -0.12 | −29.2M |
| FY2022 | 14.7M | +238.7% | −26.3M | -178.7% | -0.15 | 646K |
| FY2021 | 4.3M | +137.7% | −43.0M | -991.0% | -0.26 | −23.9M |
| FY2020 | 1.8M | -48.1% | −20.6M | -1,130.8% | -0.14 | −19.8M |
| FY2019 | 3.5M | -29.5% | −11.7M | -333.1% | -0.08 | −32.4M |
| FY2018 | 5.0M | – | −46.0M | -922.0% | -0.36 | −31.4M |